Larimar Therapeutics
LRMR
LRMR
40 hedge funds and large institutions have $28.2M invested in Larimar Therapeutics in 2022 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 4 increasing their positions, 14 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less funds holding in top 10
Funds holding in top 10: →
less capital invested
Capital invested by funds: $ → $
71% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 14
80% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 5
Holders
40
Holding in Top 10
1
Calls
$22K
Puts
–
Top Buyers
1 | +$115K | |
2 | +$5.49K | |
3 | +$1.54K | |
4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$74 |
Top Sellers
1 | -$586K | |
2 | -$491K | |
3 | -$405K | |
4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$224K |
5 |
Two Sigma Advisers
New York
|
-$57K |